Sample | Title | Value | Rank |
GSM967852 | U87-EV human glioblastoma xenograft - Control 1 | 5.30142 | 78 |
GSM967853 | U87-EV human glioblastoma xenograft - Control 2 | 5.2648 | 77 |
GSM967854 | U87-EV human glioblastoma xenograft - Control 3 | 4.77036 | 73 |
GSM967855 | U87-EV human glioblastoma xenograft - Control 4 | 5.35874 | 77 |
GSM967856 | U87-EV human glioblastoma xenograft - Control 5 | 5.23039 | 77 |
GSM967862 | U87-EV human glioblastoma xenograft - Bevacizumab treated 1 | 5.65218 | 81 |
GSM967863 | U87-EV human glioblastoma xenograft - Bevacizumab treated 2 | 5.46054 | 80 |
GSM967864 | U87-EV human glioblastoma xenograft - Bevacizumab treated 3 | 5.34478 | 78 |
GSM967865 | U87-EV human glioblastoma xenograft - Bevacizumab treated 4 | 5.4467 | 78 |
GSM967857 | U87-EV human glioblastoma xenograft - dibenzazepine treated 1 | 5.17687 | 76 |
GSM967858 | U87-EV human glioblastoma xenograft - dibenzazepine treated 2 | 5.24879 | 77 |
GSM967859 | U87-EV human glioblastoma xenograft - dibenzazepine treated 3 | 5.28346 | 77 |
GSM967860 | U87-EV human glioblastoma xenograft - dibenzazepine treated 4 | 5.42403 | 78 |
GSM967861 | U87-EV human glioblastoma xenograft - dibenzazepine treated 5 | 5.43177 | 79 |